These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17034443)

  • 1. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users.
    Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A
    Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of orally administered diacetylmorphine substitution treatment.
    Frick U; Rehm J; Zullino D; Fernando M; Wiesbeck G; Ammann J; Uchtenhagen A
    Eur Addict Res; 2010; 16(3):131-8. PubMed ID: 20424457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.
    Oviedo-Joekes E; March JC; Romero M; Perea-Milla E
    Drug Alcohol Rev; 2010 Jan; 29(1):75-80. PubMed ID: 20078686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
    Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
    Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
    Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
    Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
    Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
    Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
    Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
    Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM; Faggiano F; Amato L; Salamina G; Davoli M; Mathis F; Cuomo L; Schifano P; Burroni P; Perucci CA;
    Subst Use Misuse; 2006; 41(14):1861-79. PubMed ID: 17162594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.